Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Operating cash flow minus capital expenditures
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-16.00M | +17.3% |
| 2024 | $-19.36M | +3.4% |
| 2023 | $-20.03M | +6.6% |
| 2022 | $-21.45M | +3.8% |
| 2021 | $-22.30M | -152.2% |
| 2020 | $-8.84M | +53.2% |
| 2019 | $-18.88M | +6.2% |
| 2018 | $-20.12M | +4.2% |
| 2017 | $-21.01M | +20.8% |
| 2016 | $-26.52M | - |